CRISPR Therapeutics Appoints Chief Technical Officer

Company CRISPR Therapeutics Event Type Leadership appointment (CTO; source-gap recovery) Modality Gene editing (ex vivo, in vivo, cell therapy, RNA) Asset Technical operations across the portfolio Target Not applicable Disease Area Company-wide (SCD, TDT, cardiovascular, oncology) Summary CRISPR Therapeutics appointed Sivakesava (Siva) Sakhamuri, PhD, as…